Health Trials

Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital

ConditionsInflammatory Bowel Disease (IBD)SpondylarthropathiesTNF-alpha Inhibitors
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorMohamed Nasr

About this trial

Prevelance of axial spondylosis arthritis in inflammatory bowel disease and its RESPONSE to tumour necrosis factor (TNF) inhibitors TREATMENT

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • TNF inhibitors
  • conventional ibd medical treatment

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Mohamed Nasr

Lead sponsor

Assiut University

Sponsor institution

Source ClinicalTrials.gov